Analysis of cases of non-immune education in newborn children
DOI:
https://doi.org/10.37800/RM.2.2023.109-116Keywords:
Non-immune dropsy of the fetus, newborn, polyhydramnios, intrauterine infectionAbstract
Relevance: Currently, non-immune fetal hydrops account for 80-85% of all identified fetal hydrops, the remaining 10-15% are associated with erythrocyte alloimmunization and are defined as fetal isoimmunization. Despite the achievements of recent years in the field of perinatology and neonatology, non-immune hydrops of the fetus still remains a pathology characterized by high mortality, both in the antenatal and postnatal periods. The survival rate of children with this pathology, according to various sources, ranges from 27 to 36%.
The study aimed to analyze cases of non-immune fetal hydrops born at the Center for Perinatology and Pediatric Cardiac Surgery (Almaty) for the period from January 2019 to December 2022 to optimize the management of this group of patients.
Materials and methods: A retrospective analysis of 8 cases of non-immune fetal hydrops in newborns who were in the neonatal intensive care unit of the “Center for Perinatology and Pediatric Cardiac Surgery” in Almaty from January 2019 to December 2022 was carried out. The course of pregnancy and the history of mothers, the data of clinical, laboratory and instrumental studies of all cases of non-immune fetal hydrops were studied.
Results: The etiology of non-immune fetal hydrops was established in all 8 (100%) cases. The lethal outcome was 62.5% due to multiple malformations, severe combined heart defects and genetic pathology c, survival rate was 37.5%.
Conclusion: With non-immune dropsy of the fetus, a comprehensive diagnostic approach is required, including the following examinations of the fetus: ultrasound, Echo-KG, karyotyping for early diagnosis. After the birth of a child, a multidisciplinary approach is needed with the involvement of complex diagnostic methods and the appointment of pathogenetic and post-syndromic treatment, which will increase the survival rate of newborns.
References
Sileo F.G., Kulkarni A., Branescu I., Homfray T., Dempsey E., Mansour S., Thilaganathan B., Bhide A., Khalil A. Non-immune fetal hydrops: etiology and outcome according to gestational age at diagnosis // Ultrasound Obstet. Gynecol. – 2020. – Vol. 56. – P. 416-421. https://doi.org/10.1002/uog.22019
Meng D., Li Q., Hu X., Wang L., Tan S., Su J., Zhang Y., Sun W., Chen B., He S., Lin F., Xie B., Chen S., Agrawal P.B., Luo S., Fu C. Etiology and Outcome of non-immune Hydrops Fetalis in Southern China: report of 1004 cases // Sci. Rep. – 2019. – Vol. 9 (1). – Art. no. 10726. https://doi.org/10.1038/s41598-019-47050-6
Vanaparthy R., Mahdy H. Hydrops Fetalis // In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2023. https://pubmed.ncbi.nlm.nih.gov/33085361/
Андреев А.В., Харламова Н.В., Межинский С.С., Песенкина А.А. Клинический случай неиммунной водянки у недоношенного ребенка с пароксизмальной тахикардией // Педиатр. – 2019. – №10(2). – С. 121-128 [Andreev A.V., Xarlamova N.V., Mezhinskij S.S., Pesenkina A.A. Klinicheskij sluchaj neimmunnoj vodyanki u nedonoshennogo rebenka s paroksizmal'noj taxikardiej // Pediatr. – 2019. – №10(2). – S. 121-128 (in Russ.)]. https://doi.org/10.17816/ped102121-128
Ota S., Sahara J., Mabuchi A., Yamomoto R, Ishii K, Mitsuda N. Perinatal and one-year outcomes of non-immune hydrops fetalis by etiology and age at diagnosis // J. Obstet. Gynaecol. Res. – 2016. – Vol. 42(4). – P. 385-391. https://doi.org/10.1111/jog.12922
Гусева О.И., Гущина М.В., Панова Т.В., Алавит И.Е., Кораблева Э.Р. Неиммунная водянка плода: есть ли шансы? // Пренат. Диагн. – 2022. – №21 (2). – С. 145-150 [Guseva O.I., Gushhina M.V., Panova T.V., Alavit I.E., Korableva E'.R. Neimmunnaya vodyanka ploda: est' li shansy? // Prenat. Diagn. – 2022. – №21 (2). – S. 145-150 (in Russ.)]. https://doi.org/10.21516/2413-1458-2022-21- 2-145-150
Бец О.Г., Хмелевская И.Г., Серёжкина А.В., Булка А.А., Ходулапова Л.Г., Являнская О.С. Клинический случай неиммунной водянки у недоношенного ребенка с наличием IgG К SARS-CoV-2 при рождении // Человек и его здоровье. – 2022. – №25(2). – C. 4-12 [Bec O.G., Xmelevskaya I.G., Seryozhkina A.V., Bulka A.A., Xodulapova L.G., Yavlyanskaya O.S. Klinicheskij sluchaj neimmunnoj vodyanki u nedonoshennogo rebenka s nalichiem IgG K SARS-CoV-2 pri rozhdenii // Chelovek i ego zdorov'e. – 2022. – №25(2). – S. 4-12 (in Russ.)]. https://doi.org/10.21626/vestnik/2022-2/01
Курцер М.А., Гнетецкая В.А., Мальмберг О.Л., Белковская М.Э., Лукаш Е.Н., Шипулин Г.А., Шипулина О.Ю., Тарасова Ю.А., Пиксасова О.В. Неиммунная водянка плода: диагностика и тактика // Акуш. Гинекол. – 2009. – №(2). – С. 37-40 [Kurcer M.A., Gneteckaya V.A., Mal'mberg O.L., Belkovskaya M.E'., Lukash E.N., Shipulin G.A., Shipulina O.Yu., Tarasova Yu.A., Piksasova O.V. Neimmunnaya vodyanka ploda: diagnostika i taktika // Akush. Ginekol. – 2009. – №(2). – S. 37-40 (in Russ.)]. https://www.cmd-online.ru/upload/iblock/648/648685e521f152f868e86bedd77c1a7b.pdf
Клинический протокол медицинского вмешательства Реанимация новорожденных: утв. 17.03.2023, Протокол №180 [Klinicheskij protokol medicinskogo vmeshatel'stva Reanimaciya novorozhdennyx: utv. 17.03.2023, Protokol №180 (in Russ.)]. https://www.nrchd.kz/images/121/Клинический%20протокол%20медицинского%20вмешательства%20Реанимация%20новорожденных_compressed.pdf
Иевеков С.А., Горелик Ю.В., Горелик К.Д. Хилоторакс. Клинические случаи // Неонатология. – 2016. – №3. – С. 57-63 [Ievekov S.A., Gorelik Yu.V., Gorelik K.D. Xilotoraks. Klinicheskie sluchai // Neonatologiya. – 2016. – №3. – S. 57-63 (in Russ.)]. https://www.neonatology-nmo.ru/ru/jarticles_neonat/229.html?SSr=100134b10c12ffffffff27c__07e7040c0c0a0e-13f3
Downloads
Published
How to Cite
Issue
Section
License
The articles published in this Journal are licensed under the CC BY-NC-ND 4.0 (Creative Commons Attribution – Non-Commercial – No Derivatives 4.0 International) license, which provides for their non-commercial use only. Under this license, users have the right to copy and distribute the material in copyright but are not permitted to modify or use it for commercial purposes. Full details on the licensing are available at https://creativecommons.org/licenses/by-nc-nd/4.0/.